Catherine Roch

1.1k citations

30 papers · 837 indexed · h-index 16

Impact in

Endocrine and Autonomic Systems top 5%
- Circadian rhythm and melatonin
Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research

Papers in

Endocrine and Autonomic Systems 11
- Circadian rhythm and melatonin 10
Experimental and Cognitive Psychology 14
- Sleep and related disorders 14

Co-authors: Izzie Jacques Namer Astrid Nehlig Claire Leroy Christoph Boss Clemens Muehlan John Gatfield Alexander Treiber François Jenck
Journals: Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)ChemMedChem (4 papers)Epilepsia (3 papers)Expert Opinion on Therapeutic Patents (2 papers)
Partner nations: Switzerland France India

In The Last Decade

Catherine Roch

29 papers receiving 823 citations

Peers

Countries citing papers authored by Catherine Roch

Since Specialization

Citations

This map shows the geographic impact of Catherine Roch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Roch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Roch more than expected).

Fields of papers citing papers by Catherine Roch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Roch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Roch. The network helps show where Catherine Roch may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Catherine Roch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine Roch Line = papers co-authored together Catherine Roch links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery and In-Vivo Characterization of K_v7 Channel Openers through a Phenotypic Approach Journal of Medicinal Chemistry ·Romain Siegrist, V. Roux, Marin Nikolai, Melanie Keßler, Honglei Wei, Andreas Mühlemann, Jens‐Uwe Peters, Catherine Roch, Meg McPherson	2025	0
2	The orexin story and orexin receptor antagonists for the treatment of insomnia Journal of Sleep Research ·Clemens Muehlan, Catherine Roch, 義孝林, Jasper Dingemanse	2023	46
3	Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia Psychopharmacology ·Catherine Roch, Giorgio Bergamini, Michel A. Steiner, Martine Clozel	2021	43
4	The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders ChemMedChem ·Christoph Boss, John Gatfield, Christine Brotschi, В. В. Юрків, Thierry Sifferlen, Markus von Raumer, G. Schmidt, IG Teixeira, Alexander Treiber, Catherine Roch	2020	36
5	Discovery and evaluation of Cav3.2-selective T-type calcium channel blockers Bioorganic & Medicinal Chemistry Letters ·V. Roux, F Barrera, Gary A. Guiroux, Catherine Roch, Melanie Keßler, Eric A. Ertel, Richard Moon, Diep Ngoc Pham, Thomas Pfeifer, Ali Mabruk	2017	5
6	The Use of Physiology-Based Pharmacokinetic and Pharmacodynamic Modeling in the Discovery of the Dual Orexin Receptor Antagonist ACT-541468 Journal of Pharmacology and Experimental Therapeutics ·Alexander Treiber, Ruben de Kanter, Catherine Roch, John Gatfield, Christoph Boss, Markus von Raumer, Benno Schindelholz, Clemens Muehlan, Joop van Gerven, François Jenck	2017	69
7	Discovery and evaluation of Cav3.1-selective T-type calcium channel blockers Bioorganic & Medicinal Chemistry Letters ·V. Roux, F Barrera, Gary A. Guiroux, Catherine Roch, Melanie Keßler, Richard Moon, Diep Ngoc Pham, Eric A. Ertel, Thomas Pfeifer, Ali Mabruk	2017	4
8	Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies Journal of Medicinal Chemistry ·V. Roux, В. В. Юрків, Romain Siegrist, Л З Керефова, Gary A. Guiroux, Davide Pozzi, Olivier Corminboeuf, Catherine Roch, Melanie Keßler, Eric A. Ertel, Isabelle Reymond, Thomas Pfeifer, Ruben de Kanter, L. H. P. S., Kai Ichikawa, Diep Ngoc Pham, Richard Moon, Markus Rey, Ali Mabruk, Elvire Fournier	2017	44
9	In Vitro Regeneration of Parthenocarpic Cucumber (Cucumis sativus L.) International Journal of Current Microbiology and Applied Sciences ·Magnusson Klemencic Associates Ron Klemencic, V. Selvaratnam, Catherine Roch	2017	2
10	Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold‐Hopping Approach ChemMedChem ·В. В. Юрків, John Gatfield, Catherine Roch, Alexander Treiber, Simone Tortoioli, Christine Brotschi, IG Teixeira, Martin H. Bolli, Stefan Abele, Thierry Sifferlen, François Jenck, Christoph Boss	2016	15
11	Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel Blockers Journal of Medicinal Chemistry ·F Barrera, V. Roux, Helen Dyer, P. Patamajhi, Dennis M. Downing, John Gatfield, Catherine Roch, Melanie Keßler, Johannes Mosbacher, Thomas Pfeifer, Corinna Grisostomi, Markus Rey, Eric A. Ertel, Richard Moon	2016	19
12	Substituted cyclopentanes, tetrahydrofurans and pyrrolidines as orexin-1-receptor antagonists for treatment of various CNS disorders (WO2015/055994; WO2015/124932; WO2015/124934) Expert Opinion on Therapeutic Patents ·Christoph Boss, Catherine Roch	2015	1
13	Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2 Bioorganic & Medicinal Chemistry Letters ·Thierry Sifferlen, A. Morgotti, Mónica Lira Cantú, Emmanuelle Cottreel, John Gatfield, Alexander Treiber, Catherine Roch, François Jenck, Hamed Aissaoui, IG Teixeira, Christine Brotschi, В. В. Юрків, Romain Siegrist, Christoph Boss	2015	28
14	Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists MedChemComm ·IG Teixeira, John Gatfield, Catherine Roch, Alexander Treiber, François Jenck, Martin H. Bolli, Christine Brotschi, Thierry Sifferlen, В. В. Юрків, Christoph Boss	2015	5
15	Recent trends in orexin research—2010 to 2015 Bioorganic & Medicinal Chemistry Letters ·Christoph Boss, Catherine Roch	2015	59
16	Pathogenesis and Pharmacology of Epilepsy in the Lithium‐pilocarpine Model Epilepsia ·Véronique André, Céline Dubé, Jennifer François, Claire Leroy, Zhenjun Ying, Catherine Roch, Izzie Jacques Namer, Astrid Nehlig	2007	73
17	In the lithium–pilocarpine model of epilepsy, brain lesions are not linked to changes in blood–brain barrier permeability: an autoradiographic study in adult and developing rats Experimental Neurology ·Claire Leroy, Catherine Roch, Estelle Koning, Izzie Jacques Namer, Astrid Nehlig	2003	39
18	Detection of late epilepsy by the texture analysis of MR brain images in the lithium-pilocarpine rat model Magnetic Resonance Imaging ·Prof. Vaishali Suryawanshi, Catherine Roch, Izzie Jacques Namer, J. Chambron, Y. Mauss	2002	12
19	Predictive Value of Cortical Injury for the Development of Temporal Lobe Epilepsy in 21‐day‐old Rats: An MRI Approach Using the Lithium‐pilocarpine Model Epilepsia ·Catherine Roch, Claire Leroy, Astrid Nehlig, Izzie Jacques Namer	2002	85
20	Magnetic Resonance Imaging in the Study of the Lithium–Pilocarpine Model of Temporal Lobe Epilepsy in Adult Rats Epilepsia ·Catherine Roch, Claire Leroy, Astrid Nehlig, Izzie Jacques Namer	2002	166

About Catherine Roch

Catherine Roch is a scholar working on Endocrine and Autonomic Systems, Experimental and Cognitive Psychology, Cognitive Neuroscience, Cellular and Molecular Neuroscience and Psychiatry and Mental health, having authored 30 papers that have together received 837 indexed citations. Recurring topics across this work include Sleep and related disorders (14 papers), Sleep and Wakefulness Research (14 papers), Circadian rhythm and melatonin (10 papers), Neuroscience and Neuropharmacology Research (8 papers), Epilepsy research and treatment (7 papers), Ion channel regulation and function (5 papers), Plant tissue culture and regeneration (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). The work is most often cited by research in Endocrine and Autonomic Systems (214 citations), Cellular and Molecular Neuroscience (315 citations), Experimental and Cognitive Psychology (221 citations), Psychiatry and Mental health (248 citations) and Cognitive Neuroscience (286 citations). Catherine Roch has collaborated with scholars based in Switzerland, France and India. Frequent co-authors include Izzie Jacques Namer, Astrid Nehlig, Claire Leroy, Christoph Boss, Clemens Muehlan, John Gatfield, Alexander Treiber, François Jenck, Jasper Dingemanse and Martine Clozel. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, ChemMedChem, Epilepsia and Expert Opinion on Therapeutic Patents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact